BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30782616)

  • 1. Analysis of Mucosal Melanoma Whole-Genome Landscapes Reveals Clinically Relevant Genomic Aberrations.
    Zhou R; Shi C; Tao W; Li J; Wu J; Han Y; Yang G; Gu Z; Xu S; Wang Y; Wang L; Wang Y; Zhou G; Zhang C; Zhang Z; Sun S
    Clin Cancer Res; 2019 Jun; 25(12):3548-3560. PubMed ID: 30782616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Genomic Profiling of Acral Melanoma.
    Yeh I; Jorgenson E; Shen L; Xu M; North JP; Shain AH; Reuss D; Wu H; Robinson WA; Olshen A; von Deimling A; Kwok PY; Bastian BC; Asgari MM
    J Natl Cancer Inst; 2019 Oct; 111(10):1068-1077. PubMed ID: 30657954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-Analysis and Systematic Review of the Genomics of Mucosal Melanoma.
    Broit N; Johansson PA; Rodgers CB; Walpole ST; Newell F; Hayward NK; Pritchard AL
    Mol Cancer Res; 2021 Jun; 19(6):991-1004. PubMed ID: 33707307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candidate therapeutic agents in a newly established triple wild-type mucosal melanoma cell line.
    Shi C; Gu Z; Xu S; Ju H; Wu Y; Han Y; Li J; Li C; Wu J; Wang L; Li J; Zhou G; Ye W; Ren G; Zhang Z; Zhou R
    Cancer Commun (Lond); 2022 Jul; 42(7):627-647. PubMed ID: 35666052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets.
    Newell F; Kong Y; Wilmott JS; Johansson PA; Ferguson PM; Cui C; Li Z; Kazakoff SH; Burke H; Dodds TJ; Patch AM; Nones K; Tembe V; Shang P; van der Weyden L; Wong K; Holmes O; Lo S; Leonard C; Wood S; Xu Q; Rawson RV; Mukhopadhyay P; Dummer R; Levesque MP; Jönsson G; Wang X; Yeh I; Wu H; Joseph N; Bastian BC; Long GV; Spillane AJ; Shannon KF; Thompson JF; Saw RPM; Adams DJ; Si L; Pearson JV; Hayward NK; Waddell N; Mann GJ; Guo J; Scolyer RA
    Nat Commun; 2019 Jul; 10(1):3163. PubMed ID: 31320640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma.
    Hintzsche JD; Gorden NT; Amato CM; Kim J; Wuensch KE; Robinson SE; Applegate AJ; Couts KL; Medina TM; Wells KR; Wisell JA; McCarter MD; Box NF; Shellman YG; Gonzalez RC; Lewis KD; Tentler JJ; Tan AC; Robinson WA
    Melanoma Res; 2017 Jun; 27(3):189-199. PubMed ID: 28296713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.
    Wiesner T; Kutzner H; Cerroni L; Mihm MC; Busam KJ; Murali R
    Pathology; 2016 Feb; 48(2):113-31. PubMed ID: 27020384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The identification of patient-specific mutations reveals dual pathway activation in most patients with melanoma and activated receptor tyrosine kinases in BRAF/NRAS wild-type melanomas.
    Appenzeller S; Gesierich A; Thiem A; Hufnagel A; Jessen C; Kneitz H; Regensburger M; Schmidt C; Zirkenbach V; Bischler T; Schilling B; Siedel C; Goebeler ME; Houben R; Schrama D; Gehrig A; Rost S; Maurus K; Bargou R; Rosenwald A; Schartl M; Goebeler M; Meierjohann S
    Cancer; 2019 Feb; 125(4):586-600. PubMed ID: 30561760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic Classification of Cutaneous Melanoma.
    Cancer Genome Atlas Network
    Cell; 2015 Jun; 161(7):1681-96. PubMed ID: 26091043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations.
    Cosgarea I; Ugurel S; Sucker A; Livingstone E; Zimmer L; Ziemer M; Utikal J; Mohr P; Pfeiffer C; Pföhler C; Hillen U; Horn S; Schadendorf D; Griewank KG; Roesch A
    Oncotarget; 2017 Jun; 8(25):40683-40692. PubMed ID: 28380455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic Landscapes of Acral Melanomas in East Asia.
    Chang JW; Hsieh JJ; Wu CE; Lim AH; Ng CC; Teh BT; Chan JY
    Cancer Genomics Proteomics; 2021; 18(1):83-92. PubMed ID: 33419898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas.
    Griewank KG; Westekemper H; Murali R; Mach M; Schilling B; Wiesner T; Schimming T; Livingstone E; Sucker A; Grabellus F; Metz C; Süsskind D; Hillen U; Speicher MR; Woodman SE; Steuhl KP; Schadendorf D
    Clin Cancer Res; 2013 Jun; 19(12):3143-52. PubMed ID: 23633454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct sets of genetic alterations in melanoma.
    Curtin JA; Fridlyand J; Kageshita T; Patel HN; Busam KJ; Kutzner H; Cho KH; Aiba S; Bröcker EB; LeBoit PE; Pinkel D; Bastian BC
    N Engl J Med; 2005 Nov; 353(20):2135-47. PubMed ID: 16291983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic alterations in the melanoma genome: a high-resolution array-based comparative genomic hybridization study.
    Gast A; Scherer D; Chen B; Bloethner S; Melchert S; Sucker A; Hemminki K; Schadendorf D; Kumar R
    Genes Chromosomes Cancer; 2010 Aug; 49(8):733-45. PubMed ID: 20544847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic profiling of malignant melanoma using tiling-resolution arrayCGH.
    Jönsson G; Dahl C; Staaf J; Sandberg T; Bendahl PO; Ringnér M; Guldberg P; Borg A
    Oncogene; 2007 Jul; 26(32):4738-48. PubMed ID: 17260012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characterization of genetic alterations in primary human melanomas carrying BRAF or NRAS mutation].
    Lázár V
    Magy Onkol; 2013 Jun; 57(2):96-9. PubMed ID: 23795354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational landscape of oral mucosal melanoma based on comprehensive cancer genomic profiling tests in a Japanese cohort.
    Ichimura N; Urata Y; Kobayashi T; Hibi H
    Oral Oncol; 2024 May; 152():106807. PubMed ID: 38615585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanocytic Skin Neoplasms: What Lesson From Genomic Aberrations?
    Urso C
    Am J Dermatopathol; 2019 Sep; 41(9):623-629. PubMed ID: 31433323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization.
    Lázár V; Ecsedi S; Vízkeleti L; Rákosy Z; Boross G; Szappanos B; Bégány A; Emri G; Adány R; Balázs M
    Melanoma Res; 2012 Jun; 22(3):202-14. PubMed ID: 22456166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibility.
    Wilmott JS; Johansson PA; Newell F; Waddell N; Ferguson P; Quek C; Patch AM; Nones K; Shang P; Pritchard AL; Kazakoff S; Holmes O; Leonard C; Wood S; Xu Q; Saw RPM; Spillane AJ; Stretch JR; Shannon KF; Kefford RF; Menzies AM; Long GV; Thompson JF; Pearson JV; Mann GJ; Hayward NK; Scolyer RA
    Int J Cancer; 2019 Mar; 144(5):1049-1060. PubMed ID: 30178487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.